Bombay High Court Bars ‘LIVOGEM’ Use, Cites Risk of Confusion with P&G’s ‘LIVOGEN’ in Pharma Market

Bombay High Court Bars ‘LIVOGEM’ Use, Cites Risk of Confusion with P&G’s ‘LIVOGEN’ in Pharma Market Introduction The Bombay High Court granted an interim injunction in favour of Procter & Gamble Health Limited, restraining the use of the mark “LIVOGEM” on the ground of prima facie trademark infringement of its registered marks “LIVOGEN” and “LIVOGEN-Z”.

... Continue Reading.

Zarhouni & El Hassani Law Firm Advised AEGIS Ventures And Reda Bakkali On Acquisition Of Majority Stake In SEKERA

Zarhouni & El Hassani Law Firm advised AEGIS Ventures and Reda Bakkali on acquisition of majority stake in SEKERA The Casablanca-based business law firm, Zarhouni & El Hassani Law Firm advised AEGIS Ventures and Reda Bakkali on the acquisition of a majority stake in SEKERA, a leading cybersecurity company operating in Morocco and France. The

... Continue Reading.

Delhi High Court Revives PADAN Trademark Suit, Warns Against Premature Rejection of Plaint Under Order VII Rule 11

Delhi High Court Revives PADAN Trademark Suit, Warns Against Premature Rejection of Plaint Under Order VII Rule 11 Introduction The Delhi High Court set aside the rejection of a trademark suit concerning the “PADAN” mark, holding that a plaint cannot be dismissed at the threshold if it discloses a triable cause of action. The Court

... Continue Reading.

Delhi High Court Brands Counterfeit Supplements a Public Health Threat, Injuncts Fake ‘ISOPURE’ Network

Delhi High Court Brands Counterfeit Supplements a Public Health Threat, Injuncts Fake ‘ISOPURE’ Network Introduction The Delhi High Court granted a temporary injunction in favour of GPN Commercial LLC, restraining multiple unknown entities from manufacturing and selling counterfeit products under the “ISOPURE” trademark. The Court emphasized that counterfeiting poses serious risks not only to brand

... Continue Reading.

Delhi High Court Denies Patent on Cancer Screening Method, Holds Treatment-Guiding Tests as Non-Patentable Diagnostics

Delhi High Court Denies Patent on Cancer Screening Method, Holds Treatment-Guiding Tests as Non-Patentable Diagnostics Introduction The Delhi High Court upheld the rejection of a patent application filed by Geron Corporation for a cancer-related screening method, holding that the claimed invention constitutes a non-patentable diagnostic process under Section 3(i) of the Patents Act, 1970. The

... Continue Reading.